Astellas Pharma Ltd

3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419583
Medical Information Direct Line: 0800 783 5018
Medical Information e-mail: medinfo@gb.astellas.com

Patient Information Leaflet last updated on the eMC: 08/08/2011
PIL Protopic 0.03% Ointment

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to MA holder contact details
Updated on 06/05/2011 and displayed until 08/08/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 03/11/2009 and displayed until 06/05/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Marketing Authorisation Holder
  • Change to dosage and administration
Updated on 05/02/2009 and displayed until 03/11/2009
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 10/07/2006 and displayed until 05/02/2009
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 09/08/2005 and displayed until 10/07/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 30/06/2004 and displayed until 09/08/2005
Reasons for adding or updating:
  • Change to Further Information section
Updated on 26/09/2002 and displayed until 30/06/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   tacrolimus monohydrate